In pelvic floor dysfunction , there is faulty coordination of the muscles that facilitate expulsion of stool from the rectum
As a diagnostic agent, a single intravenous dose of sermorelin (about 1 g/kg) was used as a provocative test of pituitary GH-secretory capacity, notable for producing relatively few false-positive results compared with some other provocative tests
Epidemiology Gamma-glutamylcysteine synthetase deficiency is very rare disease
Dec 18, 2025, 08:00 ET CagriSema 2.4 mg/2.4 mg is an investigational fixed-dose injectable medicine that combines the novel amylin analogue, cagrilintide, with semaglutide to target complementary obesity-related pathways 1,2 In the REDEFINE 1 phase 3 trial, adults with obesity, or overweight with at least one obesity-related complication, taking CagriSema lost an average of 23% body weight when evaluating the treatment effect if all patients stayed on treatment *2 Novo Nordisk continues to build on its 100-year-plus legacy of science and innovation, with potential new treatments in obesity PLAINSBORO, N.J